Use of Biological Treatments in Elderly Patients with Skin Psoriasis in the Real World

Autor: Cristina Galache Osuna, Sebastián Reyes García, Jimena Carrero Martín, Virginia García Jiménez, Francisco Vázquez López, Jorge Santos-Juanes

Publikováno v: Life, Vol 11, Iss 12, p 1348 (2021)

Biological drugs have prompted a revolution in the treatment of patients with psoriasis because of their favourable efficacy/risk profile. The aims of our study are to determine whether there is any difference in the pattern of use of biological trea

Externí odkaz: https://doaj.org/article/531567404c6f46788559ea390754f547

Acne Inversa-like Lesions Induced by a Low Dose of Sorafenib

Autor: Javier Aubán-Pariente, Laura Palacios-García, Cristina Galache-Osuna, Marc Mir-Bonafé, Patricia Morales Del Burgo, Jorge Santos-Juanes

Publikováno v: Dermatology Practical & Conceptual, Vol 11, Iss 2 (2021)

Externí odkaz: https://doaj.org/article/7643c2e0c7e34c38989ea4bb94d7f908

Spectrum of comorbid autoimmune diseases in patients with chondrodermatitis nodularis helicis: a 17-year retrospective study of 215 patients in Asturias, northern Spain

Autor: Francisco, Vázquez-López, Jimena, Carrero Martín, Celia, Gómez de Castro, Blanca, Vivanco-Allende, Cristina, Galache Osuna

Publikováno v: European journal of dermatology : EJD. 32(3)

The cause of chondrodermatitis nodularis helicis (CN) (Winkler’s disease) is unknown, but potential associations with autoimmune diseases have been suggested in case reports, however, studies with large case series are lacking.To clarify the freque

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9111f6152107cd87f799c8a0b74f0484
https://pubmed.ncbi.nlm.nih.gov/36065543

Retrospective study of apremilast drug survival in psoriasis patients in a daily practice setting: A long-term experience

Autor: Cristina Galache‐Osuna, Sebastián Reyes‐García, Esther Salgueiro, Javier Bordallo‐Landa, Ana Lozano, Francisco Vázquez‐López, Jorge Santos‐Juanes

Publikováno v: Dermatologic therapyREFERENCES. 35(7)

There is limited evidence about the real-world survival of apremilast in patients with psoriasis, especially over the long term. To evaluate the long-term survival of apremilast and its predictive factors when used to treat psoriasis. A retrospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4750eefb059922a62ed7439d0a055d5e
https://pubmed.ncbi.nlm.nih.gov/35567525

Ustekinumab Drug Survival in Patients with Psoriasis: A retrospective Study of Real Clinical Practice

Autor: Borja Gómez-Vila, Laura Palacios García, Celia Gómez de Castro, Francisco Vázquez López, Jorge Santos-Juanes, Cristina Galache Osuna, Lucía Fernández, Sheila Requena López, Javier Aubán Pariente, Beatriz Vázquez Losada, Santiago Gómez Díez, Álvaro de Dios Velázquez

Publikováno v: Medicina
Volume 56
Issue 11
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Medicina, Vol 56, Iss 584, p 584 (2020)
Medicina; Volume 56; Issue 11; Pages: 584
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)

Background and objectives: The efficacy and safety of ustekinumab have been proved in clinical trials. In daily clinical practice, knowing the factors that determine survival differences of biological drugs allows psoriasis treatment to be optimized

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c241234fb0b56ab852eced5fc0b6763